ReviewThe blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms
Introduction
Cannabis is the third most prevalent psychoactive substance worldwide, only after alcohol and tobacco. The annual global estimated prevalence of cannabis use, during the last 12 months, is about 3.9%, meaning that a total of approximately 192 million people aged between 15 and 64 years have used cannabis in 2016 (United Nations Office on Drugs and Crime, 2018).
Cannabis legislative frameworks are evolving worldwide. As of November 2017, medical use, and consequently, production and sale of cannabis is allowed in Australia, Canada, Chile, Colombia, Germany, Israel, Jamaica, The Netherlands, Peru, and in 29 US states (Abuhasira et al, 2018). The recreational use of cannabis has been approved in eight states of the USA, plus the District of Columbia, Uruguay and Canada, which means that new frameworks for controlling the production, distribution and sale of cannabis have been put in place (Government of Canada, 2018). In countries like Spain, Belgium and The Netherlands, cannabis has an ambiguous legal situation and laws concerning production, distribution and sale are not settled yet (United Nations Office on Drugs and Crime, 2018).
These legal changes reflect in part a social perception of decreased risks associated to cannabis (United Nations Office of Drugs and Crime, 2017). In Western countries, and regardless of its legal situation, risk perception of cannabis use is closer to that of alcohol and tobacco than to illicit drugs such as cocaine or heroin. This could contribute to higher cannabis use prevalence (Parker and Anthony, 2018) and in fact, the prevalence of cannabis use in these countries is much closer to alcohol and tobacco than to illegal drugs (United Nations Office on Drugs and Crime, 2018).
Such high prevalence and low social risk perception point to the need to develop secondary prevention strategies aiming at the early identification of risky cannabis users (Casajuana et al., 2016). However, an appropriate identification of ‘risky use’ is still needed, since the literature on the harms associated to cannabis use is scarce and often inconclusive, not discriminating for instance between different types of marijuana (mixed delta-9THC/cannabidiol, mixtures from “skunk”). Narrative and systematic reviews have been conducted on several dimensions of cannabis related harm (Hall, 2015; “WHO | Cannabis,” 2010). More specifically, the American Academies of Science report summarizes the evidence regarding multiple health effects of cannabis and cannabinoid use (National Academies of Sciences, Engineering, 2017). Nevertheless, a global view from a public health perspective is still lacking (Fischer et al/, n.d.).
Hence, the aim of this work is to systematically review all systematic reviews on cannabis related harms, as a first step in the assessment of global risks associated to cannabis use, which in the end should inform the definition of cannabis risky use.
Section snippets
Experimental procedures
This systematic review was based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Liberati et al., 2009). This protocol provides a checklist for reporting systematic reviews (Table 1). The study protocol was registered with PROSPERO (registration number: CRD42018089130).
Results
We found 6,725 unique entries of systematic reviews and meta-analyses. Finally, 44 publications were included (Fig. 1). The results of the quality assessment indicated an AMSTAR 2 average of 60.1% affirmative punctuation.
The six dimensions previously included for the search strategy resulted in three domains: 1) mental health (Table 2); 2) somatic (Table 3); 3) injury and mortality (Table 4). Main results are synthesized in Table 5.
Discussion
This systematic review aimed to identify the impact of cannabis use on different health outcomes in order to generate a global picture of cannabis-related harms. We identified 44 systematic reviews, which included 1,053 articles covering a broad spectrum of negative health outcomes directly linked to cannabis use. However, some difficulties arise when pulling together the results.
Frequency and more particularly quantity of cannabis used are usually vaguely defined. More specifically, there is
Funding
This study is funded by the Spanish grant of Plan Nacional Sobre Drogas, Ministerio de Sanidad y Consumo (PNSD 132373 - 2017I053 - 603; Antoni Gual Solé). The conclusions of the article are only the responsibility of the authors and do not necessarily represent the official views of the institutions, who had no further role in study design, collection, analysis and interpretation of the data; in the writing of the paper; or in the decision to submit the paper for publication.
H.L.-P. received
Contributions
MB, AG and HL-P designed the study. EC, HL-P, MB and AG wrote the first draft of the manuscript. All the other authors reviewed and approved the final paper.
Conflict of interest
H.L.-P.: has received travel grants from the laboratories honoraria and travel grants from Janssen and Lundbeck, none of these COI are related to the current research. The other authors declare that they have no known conflicts of interest.
Acknowledgements
CERCA Programme / Generalitat de Catalunya.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Hospital Clínic i Universitari de Barcelona.
Plan Nacional Sobre Drogas, Ministerio de Sanidad y Consumo.
Ministry of Economy and Competitiveness, Instituto de Salud Carlos III through a ‘Rıo Hortega’
Janssen and Lundbeck.
References (89)
- et al.
Medical use of cannabis and cannabinoids containing products – regulations in Europe and North America
Eur. J. Internal Med.
(2018) - et al.
Meta-analysis of neurocognition in young psychosis patients with current cannabis use
J. Psychiatr. Res.
(2018) - et al.
A literature review and meta-analyses of cannabis use and suicidality
J. Affect. Disord.
(2016) - et al.
Serotonergic psychedelics and personality: a systematic review of contemporary research
Neurosci. Biobehav. Rev.
(2018) - et al.
Acute and chronic effects of cannabinoids on human cognition—a systematic review
Biol. Psychiatry
(2016) - et al.
Risk and protective factors for depression that adolescents can modify: a systematic review and meta-analysis of longitudinal studies
J. Affect. Disord.
(2014) - et al.
Depressive symptoms and suicidal behavior after first-episode psychosis: a comprehensive systematic review
Psychiatry Res.
(2017) - et al.
Independent versus co-occurring substance use in relation to gambling outcomes in older adolescents and young adults HHS public access
J. Adolesc. Health
(2017) - et al.
Head and neck cancer among marijuana users: a meta-analysis of matched case–control studies
Arch. Oral. Biol.
(2015) - et al.
Early risk and protective factors for problem gambling: A systematic review and meta-analysis of longitudinal studies
Clin. Psychol. Rev.
(2017)
Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies
Accid. Anal. Prevent.
The effects of cannabinoid administration on sleep: a systematic review of human studies
Sleep Med. Rev.
Adverse health eff ects of non-medical cannabis use
Lancet North Am. Ed.
The association between adolescent cannabis use and anxiety: a parallel process analysis
Addict. Behav.
Lung disease associated with marijuana use
Arch Bronconeumol
Modelling possible causality in the associations between unemployment, cannabis use, and alcohol misuse
Soc. Sci. Med.
Cannabis: exercise performance and sport. A systematic review
J. Sci. Med. Sport
Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: a population-based study
Drug Alcohol Depend.
Cannabis et psychose: recherche d'un lien de causalité à partir d'une revue critique systématique de la littérature
L'Encéphale
Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies
Lancet North Am. Ed.
The role of environmental exposures as risk factors for bipolar disorder: a systematic review of longitudinal studies
J. Affect. Disord.
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Lancet North Am. Ed.
Population-level predictions from cannabis risk perceptions to active cannabis use prevalence in the United States, 1991–2014
Addict. Behav.
774: Obstetrical and neonatal outcomes in pregnancies affected by cannabis abuse or dependence
Am. J. Obstet. Gynecol.
Longitudinal associations of cannabis and illicit drug use with depression, suicidal ideation and suicidal attempts among Nova Scotia high school students
Drug Alcohol Depend.
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
Lancet (London, England)
A meta-analysis of the crash risk of cannabis-positive drivers in culpability studies—avoiding interpretational bias
Accid. Anal. Prev.
Maternal substance use during pregnancy and offspring conduct problems: a meta-analysis
Neurosci. Biobehav. Rev.
Association between cannabis use and schizotypal dimensions – a meta-analysis of cross-sectional studies
Psychiatry Res.
Estimating the harms and costs of cannabis-attributable collisions in the Canadian provinces
Drug Alcohol Depend.
Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis
BMJ
" Positive " urine testing for Cannabis is associated with increased risk of traffic crashes
J. Pharm. Biomed. Anal.
Cannabis Smoking and Risk of Lung Cancer in Men: A Pooled Analysis of Three Studies in Maghreb
The environment and disease: association or causation?
Proc. R. Soc. Med.
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use
Drug Alcohol Rev.
A systematic review of the relationship between psychological disorders or substance use and self-reported cognitive failures
Cogn. Neuropsychiatry
Definitions of risky and problematic cannabis use: a systematic review
Subst. Use Misuse
Association between substance use and the perpetration of family violence in industrialized countries
Trauma, Violence Abuse
Cannabis use among Swedish men in adolescence and the risk of adverse life course outcomes: results from a 20 year-follow-up study
Addiction
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Lancet Psychiatry
Persistency of cannabis use predicts violence following acute psychiatric discharge
Front. Psychiatry
Cited by (85)
Associations Between Cannabis Use and Mental Distress in Young People: A Longitudinal Study
2024, Journal of Adolescent HealthDimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use
2023, Journal of Psychiatric ResearchDefining cannabis risky use: Building the plane while you fly it
2023, European NeuropsychopharmacologyCannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001–2019)
2023, Drug and Alcohol Dependence